Experimental eye drug shows promise for rare Blindness-Causing disease
NCT ID NCT06852963
First seen Jan 04, 2026 · Last updated Jun 18, 2026 · Updated 26 times
Summary
This study tests an experimental drug called VP-001 for people with a rare genetic eye disease that causes vision loss. The drug is injected into the eye and aims to slow or stop further damage. Researchers will check safety and measure any changes in eyesight over about two years. The trial includes 17 adults who have already received VP-001 in earlier studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bascom Palmer Eye Institute - University of Miami
Miami, Florida, 33136, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Casey Eye Institute - OHSU
Portland, Oregon, 97239, United States
-
Kellogg Eye Center - University of Michigan
Ann Arbor, Michigan, 48105, United States
-
Retina Foundation of the Southwest
Dallas, Texas, 75231, United States
-
University of Florida College of Medicine
Jacksonville, Florida, 32209, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.